Advertisement

Applications of Nanomaterials in Neurological Diseases, Neuronal Differentiation, Neuronal Protection, and Neurotoxicity

  • Amani H. AlhibshiEmail author
  • Widyan A. Alamoudi
  • Rai K. Farooq
Chapter
  • 27 Downloads

Abstract

The central nervous system (CNS) is one of the most important systems in the human body, and thus, CNS disorders are causing a significant threat to human health. Researchers from around the world are making impressive efforts to come up with therapeutics and solutions to treat neurodegenerative disorders. However, the issue of brain targeting remains an unsolved challenge due to the blood-brain barrier (BBB) existence. Due to the many unique properties of engineered nanomaterials, their use could make it possible to overcome difficulties in the diagnosis and treatment of neurodegenerative disorders, provide promising neuroprotective strategies, and stimulate neuronal differentiation and nerve generation as a therapeutic approach. In contrast, despite the rapid development of the nanomaterials industry and the spread of its applications in the biomedical field, there is lacking evidence regarding their possible adverse health effects, and very little is known about their toxicity. Numerous in vivo and in vitro studies have emerged, providing evidence of neurotoxic effects of various types of nanoparticles (NPs), and therefore the advantages of nanomaterials should be weighed against their potential effects. In this chapter, we focused on the applications of nanomaterials in neurological disorders, neuronal differentiation, neuroprotection, and neurotoxicity.

Keywords

Nanodiagnostics Neurodegenerative disorders Neurotoxicity Oxidative stress Neuroprotection Drug delivery Blood–brain barrier Neural differentiation Neurite outgrowth Structure scaffold 

References

  1. Abdal Dayem A et al (2018) Silver Nanoparticles: Two-Faced Neuronal Differentiation-Inducing Material in Neuroblastoma (SH-SY5Y) Cells. Int J Mol Sci 19(5):1470Google Scholar
  2. Ahmed MM, Hussein MM (2017) Neurotoxic effects of silver nanoparticles and the protective role of rutin. Biomed Pharmacother 90:731–739Google Scholar
  3. Akhavan O, Ghaderi E (2014) The use of graphene in the self-organized differentiation of human neural stem cells into neurons under pulsed laser stimulation. J Mater Chem B 2(34):5602–5611Google Scholar
  4. Akhavan O et al (2016) Rolled graphene oxide foams as three-dimensional scaffolds for growth of neural fibers using electrical stimulation of stem cells. Carbon 97:71–77Google Scholar
  5. Akhtar MJ et al (2012) Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species. Int J Nanomedicine 7:845Google Scholar
  6. Albertazzi L et al (2012) In vivo distribution and toxicity of PAMAM dendrimers in the central nervous system depend on their surface chemistry. Mol Pharm 10(1):249–260Google Scholar
  7. Albrecht J et al (2007) Glutamine in the central nervous system: function and dysfunction. Front Biosci 12(332):e43Google Scholar
  8. Alghazali KM et al (2017) Functionalized gold nanorod nanocomposite system to modulate differentiation of human mesenchymal stem cells into neural-like progenitors. Sci Rep 7(1):16654Google Scholar
  9. Alghazali KM et al (2019) Plasmonic Nanofactors as Switchable Devices to Promote or Inhibit Neuronal Activity and Function. Nanomaterials 9(7):1029Google Scholar
  10. Ambesh P, Angeli DG (2015) Nanotechnology in neurology: Genesis, current status, and future prospects. Ann Indian Acad Neurol 18(4):382Google Scholar
  11. An Y et al (2010) A photoelectrochemical immunosensor based on Au-doped TiO2 nanotube arrays for the detection of α-synuclein. Chemistry–A European Journal 16(48):14439–14446Google Scholar
  12. Arulmoli J et al (2016) Combination scaffolds of salmon fibrin, hyaluronic acid, and laminin for human neural stem cell and vascular tissue engineering. Acta Biomater 43:122–138Google Scholar
  13. Ashbrook DG et al (2014) Joint genetic analysis of hippocampal size in mouse and human identifies a novel gene linked to neurodegenerative disease. BMC Genomics 15(1):850Google Scholar
  14. Attia H, Nounou H, Shalaby M (2018) Zinc oxide nanoparticles induced oxidative DNA damage, inflammation and apoptosis in rat’s brain after oral exposure. Toxics 6(2):29Google Scholar
  15. Au C et al (2007) Effects of nanoparticles on the adhesion and cell viability on astrocytes. Biol Trace Elem Res 120(1–3):248–256Google Scholar
  16. Bai J, Zhou B (2014) Titanium dioxide nanomaterials for sensor applications. Chem Rev 114(19):10131–10176Google Scholar
  17. Bailey ZS et al (2016) Cerium oxide nanoparticles improve outcome after in vitro and in vivo mild traumatic brain injury. J Neurotrauma.  https://doi.org/10.1089/neu.2016.4644
  18. Baron R, Zayats M, Willner I (2005) Dopamine-, L-DOPA-, adrenaline-, and noradrenaline-induced growth of Au nanoparticles: assays for the detection of neurotransmitters and of tyrosinase activity. Anal Chem 77(6):1566–1571Google Scholar
  19. Bataveljić D et al (2011) Imaging cellular markers of neuroinflammation in the brain of the rat model of amyotrophic lateral sclerosis. Acta Physiol Hung 98(1):27–31Google Scholar
  20. Bencsik A, Lestaevel P, Canu IG (2018) Nano-and neurotoxicology: An emerging discipline. Prog Neurobiol 160:45–63Google Scholar
  21. Bereczki E et al (2011) Liposomes functionalized with acidic lipids rescue Aβ-induced toxicity in murine neuroblastoma cells. Nanomed Nanotechnol Biol Med 7(5):560–571Google Scholar
  22. Berns EJ et al (2016) A tenascin-C mimetic peptide amphiphile nanofiber gel promotes neurite outgrowth and cell migration of neurosphere-derived cells. Acta Biomater 37:50–58Google Scholar
  23. Bhaskar S et al (2010) Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging. Part Fibre Toxicol 7(1):3Google Scholar
  24. Bird CM, Burgess N (2008) The hippocampus and memory: insights from spatial processing. Nat Rev Neurosci 9(3):182Google Scholar
  25. Bondì ML et al (2010) Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution. Nanomedicine 5(1):25–32Google Scholar
  26. Borisova T et al (2015) Neuromodulatory properties of fluorescent carbon dots: effect on exocytotic release, uptake and ambient level of glutamate and GABA in brain nerve terminals. Int J Biochem Cell Biol 59:203–215Google Scholar
  27. Brun E, Carrière M, Mabondzo A (2012) In vitro evidence of dysregulation of blood–brain barrier function after acute and repeated/long-term exposure to TiO2 nanoparticles. Biomaterials 33(3):886–896Google Scholar
  28. Calienni MN et al (2017) Nanotoxicological and teratogenic effects: a linkage between dendrimer surface charge and zebrafish developmental stages. Toxicol Appl Pharmacol 337:1–11Google Scholar
  29. Canovi M et al (2011) The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue. Biomaterials 32(23):5489–5497Google Scholar
  30. Carradori D et al (2017) The therapeutic contribution of nanomedicine to treat neurodegenerative diseases via neural stem cell differentiation. Biomaterials 123:77–91Google Scholar
  31. Celardo I et al (2011) Pharmacological potential of cerium oxide nanoparticles. Nanoscale 3(4):1411–1420Google Scholar
  32. Chen B, Li J, Borgens RB (2018) Neuroprotection by chitosan nanoparticles in oxidative stress-mediated injury. BMC Res Notes 11(1):49Google Scholar
  33. Chen T et al (2013) Multi-walled carbon nanotube increases the excitability of hippocampal CA1 neurons through inhibition of potassium channels in rat’s brain slices. Toxicol Lett 217(2):121–128Google Scholar
  34. Chernousova S, Epple M (2013) Silver as antibacterial agent: ion, nanoparticle, and metal. Angew Chem Int Ed 52(6):1636–1653Google Scholar
  35. Cho Y, Borgens RB (2012) Polymer and nano-technology applications for repair and reconstruction of the central nervous system. Exp Neurol 233(1):126–144Google Scholar
  36. Cho Y, Shi R, Borgens RB (2010) Chitosan nanoparticle-based neuronal membrane sealing and neuroprotection following acrolein-induced cell injury. Journal of Biological Engineering 4(1):2Google Scholar
  37. Choi J et al (2009) Silica-based nanoparticle uptake and cellular response by primary microglia. Environ Health Perspect 118(5):589–595Google Scholar
  38. Christopherson GT, Song H, Mao H-Q (2009) The influence of fiber diameter of electrospun substrates on neural stem cell differentiation and proliferation. Biomaterials 30(4):556–564Google Scholar
  39. Chung C-Y et al (2017) Brain-derived neurotrophic factor loaded PS80 PBCA nanocarrier for in vitro neural differentiation of mouse induced pluripotent stem cells. Int J Mol Sci 18(3):663Google Scholar
  40. Cimini A et al (2012) Antibody-conjugated PEGylated cerium oxide nanoparticles for specific targeting of Aβ aggregates modulate neuronal survival pathways. Acta Biomater 8(6):2056–2067Google Scholar
  41. Cinteza LO (2010) Quantum dots in biomedical applications: advances and challenges. Journal of Nanophotonics 4(1):042503Google Scholar
  42. Ciofani G et al (2013) Effects of cerium oxide nanoparticles on PC12 neuronal-like cells: proliferation, differentiation, and dopamine secretion. Pharm Res 30(8):2133–2145Google Scholar
  43. Coccini T et al (2015) Comparative cellular toxicity of titanium dioxide nanoparticles on human astrocyte and neuronal cells after acute and prolonged exposure. Neurotoxicology 48:77–89Google Scholar
  44. Cole NB, Murphy DD (2002) The cell biology of alpha-synuclein: a sticky problem? Neuromolecular Med 1(2):95–109Google Scholar
  45. Crucho CI, Barros MT (2017) Polymeric nanoparticles: A study on the preparation variables and characterization methods. Mater Sci Eng C 80:771–784Google Scholar
  46. Cunha C et al (2011) 3D culture of adult mouse neural stem cells within functionalized self-assembling peptide scaffolds. Int J Nanomedicine 6:943Google Scholar
  47. D’Agata F et al (2018) Magnetic nanoparticles in the central nervous system: targeting principles, applications and safety issues. Molecules 23(1):9Google Scholar
  48. D’Angelo B et al (2009) Cerium oxide nanoparticles trigger neuronal survival in a human Alzheimer disease model by modulating BDNF pathway. Current Nanoscience 5(2):167–176Google Scholar
  49. Das M et al (2007) Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. Biomaterials 28(10):1918–1925Google Scholar
  50. Dayem AA et al (2014) Biologically synthesized silver nanoparticles induce neuronal differentiation of SH-SY5Y cells via modulation of reactive oxygen species, phosphatases, and kinase signaling pathways. Biotechnol J 9(7):934–943Google Scholar
  51. de Oliveira GMT et al (2014) Transient modulation of acetylcholinesterase activity caused by exposure to dextran-coated iron oxide nanoparticles in brain of adult zebrafish. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 162:77–84Google Scholar
  52. Deng X et al (2009) Nanosized zinc oxide particles induce neural stem cell apoptosis. Nanotechnology 20(11):115101Google Scholar
  53. Deng M et al (2014) Fabrication and neuron cytocompatibility of iron oxide nanoparticles coated with silk-fibroin peptides. Colloids Surf B Biointerfaces 116:465–471Google Scholar
  54. Dillon C et al (2011) Cerium oxide nanoparticles protect against MPTP-induced dopaminergic neurodegeneration in a mouse model for Parkinson’s disease. Nanotechnology 3:451–454Google Scholar
  55. Disdier C et al (2015) Tissue biodistribution of intravenously administrated titanium dioxide nanoparticles revealed blood-brain barrier clearance and brain inflammation in rat. Part Fibre Toxicol 12(1):27Google Scholar
  56. Dowding J et al (2014) Cerium oxide nanoparticles protect against Aβ-induced mitochondrial fragmentation and neuronal cell death. Cell Death Differ 21(10):1622Google Scholar
  57. Eitan E et al (2015) Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity. Exp Neurol 273:151–160Google Scholar
  58. Elder A et al (2006) Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect 114(8):1172–1178Google Scholar
  59. Engler AJ et al (2006) Matrix elasticity directs stem cell lineage specification. Cell 126(4):677–689Google Scholar
  60. Estevez A et al (2011) Neuroprotective mechanisms of cerium oxide nanoparticles in a mouse hippocampal brain slice model of ischemia. Free Radic Biol Med 51(6):1155–1163Google Scholar
  61. Farrukh A, Zhao S, Del Campo A (2018) Microenvironments designed to support growth and function of neuronal cells. Frontiers in Materials 5:62Google Scholar
  62. Feng L et al (2010) Fluorescence imaging of APP in Alzheimer’s disease with quantum dot or Cy3: a comparative study. Zhong nan da xue xue bao. Yi xue ban= Journal of Central South University. Med Sci 35(9):903–909Google Scholar
  63. Feng ZQ et al (2018) Neurogenic differentiation of adipose derived stem cells on graphene-based mat. Korean J Couns Psychother 90:685–692Google Scholar
  64. Fernandes C, Soni U, Patravale V (2010) Nano-interventions for neurodegenerative disorders. Pharmacol Res 62(2):166–178Google Scholar
  65. Gaillard PJ et al (2012) Enhanced brain drug delivery: safely crossing the blood–brain barrier. Drug Discov Today Technol 9(2):e155–e160Google Scholar
  66. Gao X, Gu X, Chen H (2017) The Distribution and Elimination of Nanomaterials in Brain. Neurotoxicity of Nanomaterials and Nanomedicine 50:59–74Google Scholar
  67. Gao H, Jiang X (2017) Perspective on Strategies to Reduce the Neurotoxicity of Nanomaterials and Nanomedicines. Neurotoxicity of Nanomaterials and Nanomedicine 9:331–336Google Scholar
  68. Gaoe H et al (2012) Anti-glioma effect and safety of docetaxel-loaded nanoemulsion. Arch Pharm Res 35(2):333–341Google Scholar
  69. Georganopoulou DG et al (2005) Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer’s disease. Proc Natl Acad Sci 102(7):2273–2276Google Scholar
  70. Geppert M et al (2009) Accumulation of iron oxide nanoparticles by cultured brain astrocytes. J Biomed Nanotechnol 5(3):285–293Google Scholar
  71. Geppert M et al (2012) Ferritin up-regulation and transient ROS production in cultured brain astrocytes after loading with iron oxide nanoparticles. Acta Biomater 8(10):3832–3839Google Scholar
  72. Geraets L et al (2014) Tissue distribution and elimination after oral and intravenous administration of different titanium dioxide nanoparticles in rats. Part Fibre Toxicol 11(1):30Google Scholar
  73. Ghooshchian M, Khodarahmi P, Tafvizi F (2017) Apoptosis-mediated neurotoxicity and altered gene expression induced by silver nanoparticles. Toxicol Ind Health 33(10):757–764Google Scholar
  74. Gilmore JL et al (2008) Novel nanomaterials for clinical neuroscience. J Neuroimmune Pharmacol 3(2):83–94Google Scholar
  75. Group, P.S. (2004) Levodopa and the progression of Parkinson’s disease. N Engl J Med 351(24):2498–2508Google Scholar
  76. Guerzoni LP, Nicolas V, Angelova A (2017) In vitro modulation of TrkB receptor signaling upon sequential delivery of curcumin-DHA loaded carriers towards promoting neuronal survival. Pharm Res 34(2):492–505Google Scholar
  77. Guo J et al (2011) Aptamer-functionalized PEG–PLGA nanoparticles for enhanced anti-glioma drug delivery. Biomaterials 32(31):8010–8020Google Scholar
  78. Gurunathan S, Kim J-H (2017) Graphene oxide–silver nanoparticles nanocomposite stimulates differentiation in human neuroblastoma cancer cells (SH-SY5Y). Int J Mol Sci 18(12):2549Google Scholar
  79. Haddad T et al (2016) Fabrication and surface modification of poly lactic acid (PLA) scaffolds with epidermal growth factor for neural tissue engineering. Biomatter 6(1):e1231276Google Scholar
  80. Halim A et al (2018) A mini review focused on the recent applications of graphene oxide in stem cell growth and differentiation. Nanomaterials 8(9):736Google Scholar
  81. Hamsici S et al (2017) Bioactive peptide functionalized aligned cyclodextrin nanofibers for neurite outgrowth. J Mater Chem B 5(3):517–524Google Scholar
  82. Han JW et al (2017) Dual functions of silver nanoparticles in F9 teratocarcinoma stem cells, a suitable model for evaluating cytotoxicity-and differentiation-mediated cancer therapy. Int J Nanomedicine 12:7529Google Scholar
  83. Hayashi K et al (2017) The brain-specific RasGEF very-KIND is required for normal dendritic growth in cerebellar granule cells and proper motor coordination. PLoS One 12(3):e0173175Google Scholar
  84. Heckman KL et al (2013) Custom cerium oxide nanoparticles protect against a free radical mediated autoimmune degenerative disease in the brain. ACS Nano 7(12):10582–10596Google Scholar
  85. Hobson DE et al (2002) Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. JAMA 287(4):455–463Google Scholar
  86. Hoff D et al (2013) Comparison study of ferrofluid and powder iron oxide nanoparticle permeability across the blood–brain barrier. Int J Nanomedicine 8:703Google Scholar
  87. Hohnholt MC et al (2013) Handling of iron oxide and silver nanoparticles by astrocytes. Neurochem Res 38(2):227–239Google Scholar
  88. Hong S et al (2009) Sensitive and colorimetric detection of the structural evolution of superoxide dismutase with gold nanoparticles. Anal Chem 81(4):1378–1382Google Scholar
  89. Hong F et al (2015) Suppression of neurite outgrowth of primary cultured hippocampal neurons is involved in impairment of glutamate metabolism and NMDA receptor function caused by nanoparticulate TiO2. Biomaterials 53:76–85Google Scholar
  90. Hu R et al (2010) Neurotoxicological effects and the impairment of spatial recognition memory in mice caused by exposure to TiO2 nanoparticles. Biomaterials 31(31):8043–8050Google Scholar
  91. Hu Y-L et al (2011a) Toxicity evaluation of biodegradable chitosan nanoparticles using a zebrafish embryo model. Int J Nanomedicine 6:3351Google Scholar
  92. Hu R et al (2011b) Molecular mechanism of hippocampal apoptosis of mice following exposure to titanium dioxide nanoparticles. J Hazard Mater 191(1–3):32–40Google Scholar
  93. Hu K et al (2018) Neuroprotective effect of gold nanoparticles composites in Parkinson’s disease model. Nanomed Nanotechnol Biol Med 14(4):1123–1136Google Scholar
  94. Huang R et al (2010) Gene therapy using lactoferrin-modified nanoparticles in a rotenone-induced chronic Parkinson model. J Neurol Sci 290(1–2):123–130Google Scholar
  95. Huang TH et al (2016) Patterned porous silicon photonic crystals with modular surface chemistry for spatial control of neural stem cell differentiation. Nanoscale 8(21):10891–10895Google Scholar
  96. Huerta-García E et al (2014) Titanium dioxide nanoparticles induce strong oxidative stress and mitochondrial damage in glial cells. Free Radic Biol Med 73:84–94Google Scholar
  97. Huile G et al (2011) A cascade targeting strategy for brain neuroglial cells employing nanoparticles modified with angiopep-2 peptide and EGFP-EGF1 protein. Biomaterials 32(33):8669–8675Google Scholar
  98. Huo T et al (2012) Preparation, biodistribution and neurotoxicity of liposomal cisplatin following convection enhanced delivery in normal and F98 glioma bearing rats. PLoS One 7(11):e48752Google Scholar
  99. Imam SZ et al (2015) Iron oxide nanoparticles induce dopaminergic damage: in vitro pathways and in vivo imaging reveals mechanism of neuronal damage. Mol Neurobiol 52(2):913–926Google Scholar
  100. Iswarya V et al (2016) Surface capping and size-dependent toxicity of gold nanoparticles on different trophic levels. Environ Sci Pollut Res 23(5):4844–4858Google Scholar
  101. Ittner LM, Götz J (2011) Amyloid-β and tau—a toxic pas de deux in Alzheimer’s disease. Nat Rev Neurosci 12(2):67Google Scholar
  102. Iv M et al (2015) Clinical applications of iron oxide nanoparticles for magnetic resonance imaging of brain tumors. Nanomedicine 10(6):993–1018Google Scholar
  103. Jhala D, Vasita R (2015) A review on extracellular matrix mimicking strategies for an artificial stem cell niche. Polymer Reviews 55(4):561–595Google Scholar
  104. Jia G et al (2005) Cytotoxicity of carbon nanomaterials: single-wall nanotube, multi-wall nanotube, and fullerene. Environ Sci Technol 39(5):1378–1383Google Scholar
  105. Kao Y-Y et al (2012) Demonstration of an olfactory bulb–brain translocation pathway for ZnO nanoparticles in rodent cells in vitro and in vivo. J Mol Neurosci 48(2):464–471Google Scholar
  106. Kapilashrami M et al (2014) Probing the optical property and electronic structure of TiO2 nanomaterials for renewable energy applications. Chem Rev 114(19):9662–9707Google Scholar
  107. Kaushik AC et al (2018) Nano-particle mediated inhibition of Parkinson’s disease using computational biology approach. Sci Rep 8(1):9169Google Scholar
  108. Kenzaoui BH et al (2012) Induction of oxidative stress, lysosome activation and autophagy by nanoparticles in human brain-derived endothelial cells. Biochem J 441(3):813–821Google Scholar
  109. Khan H et al (2018a) Nanoparticles for biomedical applications: An overview. Nanobiomaterials 22:357–384Google Scholar
  110. Khan FA et al (2018b) Impact of nanoparticles on neuron biology: current research trends. Int J Nanomedicine 13:2767Google Scholar
  111. Khan AM et al (2019) Silver nanoparticle-induced expression of proteins related to oxidative stress and neurodegeneration in an in vitro human blood-brain barrier model. Nanotoxicology 13(2):221–239Google Scholar
  112. Khodr CE et al (2011) An alpha-synuclein AAV gene silencing vector ameliorates a behavioral deficit in a rat model of Parkinson’s disease, but displays toxicity in dopamine neurons. Brain Res 1395:94–107Google Scholar
  113. Kiessling F et al (2014) Nanoparticles for imaging: top or flop? Radiology 273(1):10–28Google Scholar
  114. Kim Y-J, Yang SI (2011) Neurotoxic effects by silica TM nanoparticle is independent of differentiation of SH-SY5Y cells. Molecular & Cellular Toxicology 7(4):381–388Google Scholar
  115. Kim JH et al (2003) The role of synaptic GTPase-activating protein in neuronal development and synaptic plasticity. J Neurosci 23(4):1119–1124Google Scholar
  116. Kim CK et al (2012) Ceria nanoparticles that can protect against ischemic stroke. Angew Chem Int Ed 51(44):11039–11043Google Scholar
  117. Kim Y et al (2013) In vivo nanoneurotoxicity screening using oxidative stress and neuroinflammation paradigms. Nanomed Nanotechnol Biol Med 9(7):1057–1066Google Scholar
  118. Kim J-H et al (2015) Zinc oxide nanoparticles induce lipoxygenase-mediated apoptosis and necrosis in human neuroblastoma SH-SY5Y cells. Neurochem Int 90:204–214Google Scholar
  119. Kosicek M et al (2010) Nano-HPLC–MS analysis of phospholipids in cerebrospinal fluid of Alzheimer’s disease patients—a pilot study. Anal Bioanal Chem 398(7–8):2929–2937Google Scholar
  120. Kreuter J (2015) Influence of chronobiology on the nanoparticle-mediated drug uptake into the brain. Pharmaceutics 7(1):3–9Google Scholar
  121. Kteeba SM et al (2018) Exposure to ZnO nanoparticles alters neuronal and vascular development in zebrafish: Acute and transgenerational effects mitigated with dissolved organic matter. Environ Pollut 242:433–448Google Scholar
  122. Kumar A et al (2017) Nanotechnology for neuroscience: promising approaches for diagnostics, therapeutics and brain activity mapping. Adv Funct Mater 27(39):1700489Google Scholar
  123. Lamkowsky MC et al (2012) Magnetic field-induced acceleration of the accumulation of magnetic iron oxide nanoparticles by cultured brain astrocytes. J Biomed Mater Res A 100(2):323–334Google Scholar
  124. Lansdown AB (2006) Silver in health care: antimicrobial effects and safety in use. Biofunctional Textiles and the Skin 8:17–34Google Scholar
  125. Lauzon M-A, Drevelle O, Faucheux N (2017) Peptides derived from the knuckle epitope of BMP-9 induce the cholinergic differentiation and inactivate GSk3beta in human SH-SY5Y neuroblastoma cells. Sci Rep 7(1):4695Google Scholar
  126. Lauzon M-A, Marcos B, Faucheux N (2018) Characterization of alginate/chitosan-based nanoparticles and mathematical modeling of their SpBMP-9 release inducing neuronal differentiation of human SH-SY5Y cells. Carbohydr Polym 181:801–811Google Scholar
  127. Lebda MA et al (2018) Potential role of α-lipoic acid and Ginkgo biloba against silver nanoparticles-induced neuronal apoptosis and blood-brain barrier impairments in rats. Life Sci 212:251–260Google Scholar
  128. Lee HY et al (2007) A practical procedure for producing silver nanocoated fabric and its antibacterial evaluation for biomedical applications. Chem Commun 28:2959–2961Google Scholar
  129. Lee TJ et al (2015) RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model. Oncotarget 6(17):14766Google Scholar
  130. Lee MK et al (2016) Three dimensional conjugation of recombinant N-cadherin to a hydrogel for in vitro anisotropic neural growth. J Mater Chem B 4(42):6803–6811Google Scholar
  131. Lee JS et al (2018) Ferritin nanoparticles for improved self-renewal and differentiation of human neural stem cells. Biomaterials Research 22(1):5Google Scholar
  132. Lein P et al (2000) Manganese induces neurite outgrowth in PC12 cells via upregulation of αv integrins. Brain Res 885(2):220–230Google Scholar
  133. Li Y et al (2010) Systematic influence induced by 3 nm titanium dioxide following intratracheal instillation of mice. J Nanosci Nanotechnol 10(12):8544–8549Google Scholar
  134. Li M et al (2013) Cerium oxide caged metal chelator: anti-aggregation and anti-oxidation integrated H 2 O 2-responsive controlled drug release for potential Alzheimer’s disease treatment. Chem Sci 4(6):2536–2542Google Scholar
  135. Liang H et al (2018) Neuroinflammation is induced by tongue-instilled ZnO nanoparticles via the Ca 2+-dependent NF-κB and MAPK pathways. Part Fibre Toxicol 15(1):39Google Scholar
  136. Liao H-Y et al (2014) Six-month follow-up study of health markers of nanomaterials among workers handling engineered nanomaterials. Nanotoxicology 8(sup1):100–110Google Scholar
  137. Lin B-L et al (2017) Superparamagnetic iron oxide nanoparticles-complexed cationic amylose for in vivo magnetic resonance imaging tracking of transplanted stem cells in stroke. Nanomaterials 7(5):107Google Scholar
  138. Liu Y, Xu Z, Li X (2013) Cytotoxicity of titanium dioxide nanoparticles in rat neuroglia cells. Brain Inj 27(7–8):934–939Google Scholar
  139. Liu S et al (2010) Oxidative stress and apoptosis induced by nanosized titanium dioxide in PC12 cells. Toxicology 267(1–3):172–177Google Scholar
  140. Liu F et al (2015) Effects of silver nanoparticles on human and rat embryonic neural stem cells. Front Neurosci 9:115Google Scholar
  141. Loane DJ, Faden AI (2010) Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies. Trends Pharmacol Sci 31(12):596–604Google Scholar
  142. Lockman PR et al (2004) Nanoparticle surface charges alter blood–brain barrier integrity and permeability. J Drug Target 12(9–10):635–641Google Scholar
  143. Low WC et al (2015) Nanofiber-mediated release of retinoic acid and brain-derived neurotrophic factor for enhanced neuronal differentiation of neural progenitor cells. Drug Deliv Transl Res 5(2):89–100Google Scholar
  144. Lu W et al (2006) Cationic albumin–conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration. Cancer Res 66(24):11878–11887Google Scholar
  145. Lu W et al (2007) Aclarubicin-loaded cationic albumin-conjugated pegylated nanoparticle for glioma chemotherapy in rats. Int J Cancer 120(2):420–431Google Scholar
  146. Luther EM et al (2013) Endocytotic uptake of iron oxide nanoparticles by cultured brain microglial cells. Acta Biomater 9(9):8454–8465Google Scholar
  147. Ma L et al (2010) Oxidative stress in the brain of mice caused by translocated nanoparticulate TiO2 delivered to the abdominal cavity. Biomaterials 31(1):99–105Google Scholar
  148. Machtoub L, Bataveljic D, Andjus P (2011) Molecular imaging of brain lipid environment of lymphocytes in amyotrophic lateral sclerosis using magnetic resonance imaging and SECARS microscopy. Physiol Res 60:S121Google Scholar
  149. Mageswari A et al (2016) Nanomaterials: classification, biological synthesis and characterization. Nanoscience in Food and Agriculture 3:31–71Google Scholar
  150. Male D, Gromnicova R, Mcquaid C (2016) Gold Nanoparticles for imaging and drug transport to the CNS. Int Rev Neurobiol 23:155–198Google Scholar
  151. Manchineella S et al (2016) Surface-functionalized silk fibroin films as a platform to guide neuron-like differentiation of human mesenchymal stem cells. ACS Appl Mater Interfaces 8(35):22849–22859Google Scholar
  152. Mao Z et al (2015) Titanium dioxide nanoparticles alter cellular morphology via disturbing the microtubule dynamics. Nanoscale 7(18):8466–8475Google Scholar
  153. Márquez-Ramírez SG et al (2012) Titanium dioxide nanoparticles inhibit proliferation and induce morphological changes and apoptosis in glial cells. Toxicology 302(2–3):146–156Google Scholar
  154. Martirosyan A, Schneider Y-J (2014) Engineered nanomaterials in food: implications for food safety and consumer health. Int J Environ Res Public Health 11(6):5720–5750Google Scholar
  155. Massard C, Deutsch E, Soria J (2006) Tumour stem cell-targeted treatment: elimination or differentiation. Ann Oncol 17(11):1620–1624Google Scholar
  156. Matsuoka Y et al (2003) Novel therapeutic approach for the treatment of Alzheimer’s disease by peripheral administration of agents with an affinity to β-amyloid. J Neurosci 23(1):29–33Google Scholar
  157. Mauter MS, Elimelech M (2008) Environmental applications of carbon-based nanomaterials. Environ Sci Technol 42(16):5843–5859Google Scholar
  158. Meena R, Kumar S, Paulraj R (2015) Titanium oxide (TiO 2) nanoparticles in induction of apoptosis and inflammatory response in brain. J Nanopart Res 17(1):49Google Scholar
  159. Meng L et al (2013) Inhibitory effects of multiwall carbon nanotubes with high iron impurity on viability and neuronal differentiation in cultured PC12 cells. Toxicology 313(1):49–58Google Scholar
  160. Mili B et al (2018) Preparation of NGF encapsulated chitosan nanoparticles and its evaluation on neuronal differentiation potentiality of canine mesenchymal stem cells. J Mater Sci Mater Med 29(1):4Google Scholar
  161. Mohammadipour A et al (2014) Maternal exposure to titanium dioxide nanoparticles during pregnancy; impaired memory and decreased hippocampal cell proliferation in rat offspring. Environ Toxicol Pharmacol 37(2):617–625Google Scholar
  162. Montesinos R (2017) Liposomal drug delivery to the central nervous system. LiposomesGoogle Scholar
  163. Mu K et al (2015) Monoclonal Antibody–Conjugated Superparamagnetic Iron Oxide Nanoparticles for Imaging of Epidermal Growth Factor Receptor–Targeted Cells and Gliomas. Mol Imaging 14(5):7290Google Scholar
  164. Murakami S, Tashiro F (2015) Prospects of Differentiation Therapy for Cancer Stem Cells. Adv Tech Biol Med 3: 144. doi: 10.4172/2379-1764.1000144 Page 2 of 5 Volume 3• Issue 3• 1000144 Adv Tech Biol Med ISSN: 2379-1764 ATBM, an open access journal were originally found in hematopoietic stem cells by the side population (SP) assay [28, 29]. The SP assay is the method for identifying CSCs using the efflux of the DNA-binding dye Hoechst 33342 [30, 31]. The expression level of the ABC transporter gene correlates with stem cell compartment characterized by SP, MDR1Google Scholar
  165. Muthiah M, Park I-K, Cho C-S (2013) Surface modification of iron oxide nanoparticles by biocompatible polymers for tissue imaging and targeting. Biotechnol Adv 31(8):1224–1236Google Scholar
  166. Myhre O et al (2013) Metal dyshomeostasis and inflammation in Alzheimer’s and Parkinson’s diseases: possible impact of environmental exposures. Oxid Med Cell Longev 2013Google Scholar
  167. Nalika N, Parvez S (2015) Mitochondrial dysfunction in titanium dioxide nanoparticle-induced neurotoxicity. Toxicol Mech Methods 25(5):355–363Google Scholar
  168. Neely A et al (2009) Ultrasensitive and highly selective detection of Alzheimer’s disease biomarker using two-photon Rayleigh scattering properties of gold nanoparticle. ACS Nano 3(9):2834–2840Google Scholar
  169. Newman MD, Stotland M, Ellis JI (2009) The safety of nanosized particles in titanium dioxide–and zinc oxide–based sunscreens. J Am Acad Dermatol 61(4):685–692Google Scholar
  170. Ngwa HA et al (2011) Manganese nanoparticle activates mitochondrial dependent apoptotic signaling and autophagy in dopaminergic neuronal cells. Toxicol Appl Pharmacol 256(3):227–240Google Scholar
  171. Nicholls FJ et al (2016) DNA–gadolinium–gold nanoparticles for in vivo T1 MR imaging of transplanted human neural stem cells. Biomaterials 77:291–306Google Scholar
  172. Nicolosi A et al (2018) Acute exposure to zinc oxide nanoparticles critically disrupts operation of the respiratory neural network in neonatal rat. Neurotoxicology 67:150–160Google Scholar
  173. Niu S et al (2017) Inhibition by multifunctional magnetic nanoparticles loaded with alpha-synuclein RNAi plasmid in a Parkinson’s disease model. Theranostics 7(2):344Google Scholar
  174. Nowack B, Krug HF, Height M (2011) 120 years of nanosilver history: implications for policy makers. ACS Publications, SwitzerlandGoogle Scholar
  175. Oberdörster E (2004) Manufactured nanomaterials (fullerenes, C60) induce oxidative stress in the brain of juvenile largemouth bass. Environ Health Perspect 112(10):1058–1062Google Scholar
  176. Oberdörster G, Stone V, Donaldson K (2007) Toxicology of nanoparticles: a historical perspective. Nanotoxicology 1(1):2–25Google Scholar
  177. Orlando A et al (2017) Mesoporous silica nanoparticles trigger mitophagy in endothelial cells and perturb neuronal network activity in a size-and time-dependent manner. Int J Nanomedicine 12:3547Google Scholar
  178. Ostrakhovitch E, Semenikhin O (2013) The role of redox environment in neurogenic development. Arch Biochem Biophys 534(1–2):44–54Google Scholar
  179. Pampaloni NP et al (2018) Sculpting neurotransmission during synaptic development by 2D nanostructured interfaces. Nanomed Nanotechnol Biol Med 14(7):2521–2532Google Scholar
  180. Panyala NR, Peña-Méndez EM, Havel J (2008) Silver or silver nanoparticles: a hazardous threat to the environment and human health? Journal of Applied Biomedicine (De Gruyter Open) 6(3):20Google Scholar
  181. Park GE, Webster TJ (2005) A review of nanotechnology for the development of better orthopedic implants. J Biomed Nanotechnol 1(1):18–29Google Scholar
  182. Park SY et al (2017) Kalopanacis Cortex extract-capped gold nanoparticles activate NRF2 signaling and ameliorate damage in human neuronal SH-SY5Y cells exposed to oxygen–glucose deprivation and reoxygenation. Int J Nanomedicine 12:4563Google Scholar
  183. Park SY et al (2019) Neuroprotective effect of Dictyopteris divaricata extract-capped gold nanoparticles against oxygen and glucose deprivation/reoxygenation. Colloids Surf B Biointerfaces 179:421–428Google Scholar
  184. Patel M (2016) Targeting oxidative stress in central nervous system disorders. Trends Pharmacol Sci 37(9):768–778Google Scholar
  185. Peres TV et al (2016) Manganese-induced neurotoxicity: a review of its behavioral consequences and neuroprotective strategies. BMC Pharmacol Toxicol 17(1):57Google Scholar
  186. Petters C, Thiel K, Dringen R (2016) Lysosomal iron liberation is responsible for the vulnerability of brain microglial cells to iron oxide nanoparticles: comparison with neurons and astrocytes. Nanotoxicology 10(3):332–342Google Scholar
  187. Petters C et al (2014) Uptake and metabolism of iron oxide nanoparticles in brain cells. Neurochem Res 39(9):1648–1660Google Scholar
  188. Pickard M, Chari D (2010) Robust uptake of magnetic nanoparticles (MNPs) by central nervous system (CNS) microglia: implications for particle uptake in mixed neural cell populations. Int J Mol Sci 11(3):967–981Google Scholar
  189. Pinna A et al (2015) Ceria nanoparticles for the treatment of Parkinson-like diseases induced by chronic manganese intoxication. RSC Adv 5(26):20432–20439Google Scholar
  190. Pisanic TR, Jin S, Shubayev VI (2009) Iron oxide magnetic nanoparticle nanotoxicity: incidence and mechanisms. Nanotoxicity: From in vivo and in Vitro Models to Health Risks 28:397–425Google Scholar
  191. Podolski IY et al (2007) Effects of hydrated forms of C60 fullerene on amyloid β-peptide fibrillization in vitro and performance of the cognitive task. J Nanosci Nanotechnol 7(4–5):1479–1485Google Scholar
  192. Polak P, Shefi O (2015) Nanometric agents in the service of neuroscience: manipulation of neuronal growth and activity using nanoparticles. Nanomed Nanotechnol Biol Med 11(6):1467–1479Google Scholar
  193. Portney NG, Ozkan M (2006) Nano-oncology: drug delivery, imaging, and sensing. Anal Bioanal Chem 384(3):620–630Google Scholar
  194. Quadros ME, Marr LC (2010) Environmental and human health risks of aerosolized silver nanoparticles. J Air Waste Manage Assoc 60(7):770–781Google Scholar
  195. Ragusa A et al (2018) Neuroprotective investigation of chitosan nanoparticles for dopamine delivery. Applied Sciences 8(4):474Google Scholar
  196. Raspa A et al (2016) A biocompatibility study of new nanofibrous scaffolds for nervous system regeneration. Nanoscale 8(1):253–265Google Scholar
  197. Ren L, Zhong W (2010) Oxidation reactions mediated by single-walled carbon nanotubes in aqueous solution. Environ Sci Technol 44(18):6954–6958Google Scholar
  198. Richert L et al (2008) Surface nanopatterning to control cell growth. Adv Mater 20(8):1488–1492Google Scholar
  199. Riggio C et al (2012) Poly-l-lysine-coated magnetic nanoparticles as intracellular actuators for neural guidance. Int J Nanomedicine 7:3155Google Scholar
  200. Riggio C et al (2014) The orientation of the neuronal growth process can be directed via magnetic nanoparticles under an applied magnetic field. Nanomed Nanotechnol Biol Med 10(7):1549–1558Google Scholar
  201. Roney CA et al (2009) Nanoparticulate radiolabelled quinolines detect amyloid plaques in mouse models of Alzheimer’s disease. International Journal of Alzheimer’s Disease 2009:12Google Scholar
  202. RUSSELL JW et al (2002) High glucose-induced oxidative stress and mitochondrial dysfunction in neurons. FASEB J 16(13):1738–1748Google Scholar
  203. Rzigalinski BA (2005) Nanoparticles and cell longevity. Technol Cancer Res Treat 4(6):651–659Google Scholar
  204. Rzigalinski BA, Carfagna CS, Ehrich M (2017) Cerium oxide nanoparticles in neuroprotection and considerations for efficacy and safety. Wiley Interdiscip Rev Nanomed Nanobiotechnol 9(4):e1444Google Scholar
  205. Safari M, Arbabi Bidgoli S, Rezayat S (2016) Differential neurotoxic effects of silver nanoparticles: A review with special emphasis on potential biomarkers. Nanomedicine Journal 3(2):83–94Google Scholar
  206. Saleh TA, Gupta VK (2016) Chapter 4—Synthesis, classification, and properties of nanomaterials. In: Saleh TA, Gupta VK (eds) Nanomaterial and Polymer Membranes. Elsevier, Amsterdam, The Netherlands, pp 83–133Google Scholar
  207. Salim S (2017) Oxidative stress and the central nervous system. Journal of Pharmacology and Experimental Therapeutics 360(1):201–205Google Scholar
  208. Sandhir R et al (2015) Nano-antioxidants: an emerging strategy for intervention against neurodegenerative conditions. Neurochem Int 89:209–226Google Scholar
  209. Santos T et al (2016) Nanomedicine approaches to modulate neural stem cells in brain repair. Trends Biotechnol 34(6):437–439Google Scholar
  210. Saraiva C, Ferreira L, Bernardino L (2016) Traceable microRNA-124 loaded nanoparticles as a new promising therapeutic tool for Parkinson’s disease. Neurogenesis 3(1):e1256855Google Scholar
  211. Saraiva C et al (2018) MicroRNA-124-loaded nanoparticles increase survival and neuronal differentiation of neural stem cells in vitro but do not contribute to stroke outcome in vivo. PLoS One 13(3):e0193609Google Scholar
  212. Sarkar A et al (2017) Nanoparticles as a carrier system for drug delivery across blood brain barrier. Curr Drug Metab 18(2):129–137Google Scholar
  213. Scheringer M et al (2010) Environmental risks associated with nanoparticulate silver used as biocide. Household Pers Care Today 1:34–37Google Scholar
  214. Schöneborn H et al (2019) Novel Tools towards Magnetic Guidance of Neurite Growth:(I) Guidance of Magnetic Nanoparticles into Neurite Extensions of Induced Human Neurons and In Vitro Functionalization with RAS Regulating Proteins. Journal of Functional Biomaterials 10(3):32Google Scholar
  215. Schubert D et al (2006) Cerium and yttrium oxide nanoparticles are neuroprotective. Biochem Biophys Res Commun 342(1):86–91Google Scholar
  216. Seaton A, Donaldson K (2005) Nanoscience, nanotoxicology, and the need to think small. The Lancet 365(9463):923–924Google Scholar
  217. Shadfar S et al (2015) Involvement of inflammation in Alzheimer’s disease pathogenesis and therapeutic potential of anti-inflammatory agents. Arch Pharm Res 38(12):2106–2119Google Scholar
  218. Shah B et al (2013) Multimodal Magnetic Core–Shell Nanoparticles for Effective Stem-Cell Differentiation and Imaging. Angew Chem Int Ed 52(24):6190–6195Google Scholar
  219. Shah S et al (2014) Guiding stem cell differentiation into oligodendrocytes using graphene-nanofiber hybrid scaffolds. Adv Mater 26(22):3673–3680Google Scholar
  220. Shang L, Nienhaus K, Nienhaus GU (2014) Engineered nanoparticles interacting with cells: size matters. J Nanobiotechnol 12(1):5Google Scholar
  221. Shao H et al (2018) Carbon nanotube multilayered nanocomposites as multifunctional substrates for actuating neuronal differentiation and functions of neural stem cells. Biomaterials 175:93–109Google Scholar
  222. Shim KH et al (2014) Analysis of zinc oxide nanoparticles binding proteins in rat blood and brain homogenate. Int J Nanomedicine 9(Suppl 2):217Google Scholar
  223. Singh N, Cohen CA, Rzigalinski BA (2007) Treatment of neurodegenerative disorders with radical nanomedicine. Ann N Y Acad Sci 1122(1):219–230Google Scholar
  224. Singh N et al (2008) The antioxidant activity of cerium oxide nanoparticles is size dependent and blocks Aβ1-42-induced free radical production and neurotoxicity. Federation of American Societies for Experimental Biology 5(2):15Google Scholar
  225. Singh N et al (2017) Drug delivery: advancements and challenges. Nanostructures for Drug Delivery 43:865–886Google Scholar
  226. Skaper SD et al (2018) An inflammation-centric view of neurological disease: beyond the neuron. Front Cell Neurosci 12:72Google Scholar
  227. Smith CJ, Shaw BJ, Handy RD (2007) Toxicity of single walled carbon nanotubes to rainbow trout (Oncorhynchus mykiss): respiratory toxicity, organ pathologies, and other physiological effects. Aquat Toxicol 82(2):94–109Google Scholar
  228. Solanki A et al (2013) Nanotopography-mediated reverse uptake for siRNA delivery into neural stem cells to enhance neuronal differentiation. Sci Rep 3:1553Google Scholar
  229. Soltani Nejad M (2015) G.H. Shahidi Bonjar, and N. Khaleghi, Biosynthesis of gold nanoparticles using streptomyces fulvissimus isolate. Nanomedicine Journal 2(2):153–159Google Scholar
  230. Song B et al (2016) Is neurotoxicity of metallic nanoparticles the cascades of oxidative stress? Nanoscale Res Lett 11(1):291Google Scholar
  231. Sousa F et al (2010) Functionalized gold nanoparticles: a detailed in vivo multimodal microscopic brain distribution study. Nanoscale 2(12):2826–2834Google Scholar
  232. Srinageshwar B et al (2017) PAMAM dendrimers cross the blood–brain barrier when administered through the carotid artery in C57BL/6J mice. Int J Mol Sci 18(3):628Google Scholar
  233. Sruthi S, Mohanan P (2015) Investigation on cellular interactions of astrocytes with zinc oxide nanoparticles using rat C6 cell lines. Colloids Surf B Biointerfaces 133:1–11Google Scholar
  234. Stephanopoulos N et al (2014) Bioactive DNA-peptide nanotubes enhance the differentiation of neural stem cells into neurons. Nano Lett 15(1):603–609Google Scholar
  235. Strużyńska L, Skalska J (2018) Mechanisms underlying neurotoxicity of silver nanoparticles. Cellular and Molecular Toxicology of Nanoparticles 18:227–250Google Scholar
  236. Sudhakaran S, Athira S, Mohanan P (2019) Zinc oxide nanoparticle induced neurotoxic potential upon interaction with primary astrocytes. Neurotoxicology 73:213–227Google Scholar
  237. Sun X et al (2012) Co-delivery of pEGFP-hTRAIL and paclitaxel to brain glioma mediated by an angiopep-conjugated liposome. Biomaterials 33(3):916–924Google Scholar
  238. Talukdar Y et al (2014) The effects of graphene nanostructures on mesenchymal stem cells. Biomaterials 35(18):4863–4877Google Scholar
  239. Tang J et al (2009) Distribution, translocation and accumulation of silver nanoparticles in rats. J Nanosci Nanotechnol 9(8):4924–4932Google Scholar
  240. Taylor M et al (2011) Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer’s Aβ peptide. Nanomed Nanotechnol Biol Med 7(5):541–550Google Scholar
  241. Teleanu DM et al (2019) Neurotoxicity of nanomaterials: An up-to-date overview. Nanomaterials 9(1):96Google Scholar
  242. Tian L et al (2015) Neurotoxicity induced by zinc oxide nanoparticles: age-related differences and interaction. Sci Rep 5:16117Google Scholar
  243. Tiwari SK et al (2013) Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer’s disease model via canonical Wnt/β-catenin pathway. ACS Nano 8(1):76–103Google Scholar
  244. Tran HNA et al (2010) A novel class of potential prion drugs: preliminary in vitro and in vivo data for multilayer coated gold nanoparticles. Nanoscale 2(12):2724–2732Google Scholar
  245. Usmani S et al (2016) 3D meshes of carbon nanotubes guide functional reconnection of segregated spinal explants. Sci Adv 2(7):e1600087Google Scholar
  246. Valdiglesias V et al (2013a) Comparative study on effects of two different types of titanium dioxide nanoparticles on human neuronal cells. Food Chem Toxicol 57:352–361Google Scholar
  247. Valdiglesias V et al (2013b) Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles. Environ Int 55:92–100Google Scholar
  248. Vidal F et al (2018) Prevention of synaptic alterations and neurotoxic effects of PAMAM dendrimers by surface functionalization. Nanomaterials 8(1):7Google Scholar
  249. Vissers C, Ming G-l, Song H (2019) Nanoparticle technology and stem cell therapy team up against neurodegenerative disorders. Adv Drug Deliv Rev 148:239–251Google Scholar
  250. Wang B et al (2007) Transport of intranasally instilled fine Fe 2 O 3 particles into the brain: micro-distribution, chemical states, and histopathological observation. Biol Trace Elem Res 118(3):233–243Google Scholar
  251. Wang J et al (2008) Biological effect of intranasally instilled titanium dioxide nanoparticles on female mice. Nano 3(04):279–285Google Scholar
  252. Wang J et al (2011a) Cytotoxicity of single-walled carbon nanotubes on PC12 cells. Toxicol In Vitro 25(1):242–250Google Scholar
  253. Wang F et al (2011b) Oxidative mechanisms contribute to nanosize silican dioxide-induced developmental neurotoxicity in PC12 cells. Toxicol In Vitro 25(8):1548–1556Google Scholar
  254. Wang Z et al (2015) Polymeric nanovehicle regulated spatiotemporal real-time imaging of the differentiation dynamics of transplanted neural stem cells after traumatic brain injury. ACS Nano 9(7):6683–6695Google Scholar
  255. Weaver CL, Cui XT (2015) Directed neural stem cell differentiation with a functionalized graphene oxide nanocomposite. Adv Healthc Mater 4(9):1408–1416Google Scholar
  256. Wiechers JW, Musee N (2010) Engineered inorganic nanoparticles and cosmetics: facts, issues, knowledge gaps and challenges. J Biomed Nanotechnol 6(5):408–431Google Scholar
  257. Wiedmer L et al (2019) Silica nanoparticle-exposure during neuronal differentiation modulates dopaminergic and cholinergic phenotypes in SH-SY5Y cells. J Nanobiotechnol 17(1):46Google Scholar
  258. Wijnhoven S et al (2008) Nano silver: A review of available data and knowledge gaps. RIVM Briefrapport, 360003001Google Scholar
  259. Win-Shwe T-T, Fujimaki H (2011) Nanoparticles and neurotoxicity. Int J Mol Sci 12(9):6267–6280Google Scholar
  260. Wu J, Sun J (2011) Investigation on mechanism of growth arrest induced by iron oxide nanoparticles in PC12 cells. J Nanosci Nanotechnol 11(12):11079–11083Google Scholar
  261. Wu J, Sun J, Xue Y (2010) Involvement of JNK and P53 activation in G2/M cell cycle arrest and apoptosis induced by titanium dioxide nanoparticles in neuron cells. Toxicol Lett 199(3):269–276Google Scholar
  262. Wu J et al (2009) Toxicity and penetration of TiO2 nanoparticles in hairless mice and porcine skin after subchronic dermal exposure. Toxicol Lett 191(1):1–8Google Scholar
  263. Wu D et al (2012) Multi-walled carbon nanotubes inhibit regenerative axon growth of dorsal root ganglia neurons of mice. Neurosci Lett 507(1):72–77Google Scholar
  264. Wu H-Y et al (2013) Iron oxide nanoparticles suppress the production of IL-1beta via the secretory lysosomal pathway in murine microglial cells. Part Fibre Toxicol 10(1):46Google Scholar
  265. Wu T et al (2016) Research advances on potential neurotoxicity of quantum dots. J Appl Toxicol 36(3):345–351Google Scholar
  266. Xiao SJ et al (2010) Sensitive discrimination and detection of prion disease-associated isoform with a dual-aptamer strategy by developing a sandwich structure of magnetic microparticles and quantum dots. Anal Chem 82(23):9736–9742Google Scholar
  267. Xie M et al (2010) PEG-interspersed nitrilotriacetic acid-functionalized quantum dots for site-specific labeling of prion proteins expressed on cell surfaces. Biomaterials 31(32):8362–8370Google Scholar
  268. Xing D, Ma L, Gao C (2017) A bioactive hyaluronic acid–based hydrogel cross-linked by Diels–Alder reaction for promoting neurite outgrowth of PC12 cells. Journal of Bioactive and Compatible Polymers 32(4):382–396Google Scholar
  269. Xu L et al (2015) Silver nanoparticles induce tight junction disruption and astrocyte neurotoxicity in a rat blood–brain barrier primary triple coculture model. Int J Nanomedicine 10:6105Google Scholar
  270. Xue Y, Wu J, Sun J (2012) Four types of inorganic nanoparticles stimulate the inflammatory reaction in brain microglia and damage neurons in vitro. Toxicol Lett 214(2):91–98Google Scholar
  271. Xue J et al (2019) Neuroprotective effect of biosynthesised gold nanoparticles synthesised from root extract of Paeonia moutan against Parkinson disease–In vitro & In vivo model. J Photochem Photobiol B Biol 200:111635Google Scholar
  272. Yamamoto S et al (2006) Brain cytokine and chemokine mRNA expression in mice induced by intranasal instillation with ultrafine carbon black. Toxicol Lett 163(2):153–160Google Scholar
  273. Yang J et al (2011) Detection of amyloid plaques targeted by USPIO-Aβ1–42 in Alzheimer’s disease transgenic mice using magnetic resonance microimaging. Neuroimage 55(4):1600–1609Google Scholar
  274. Yang X et al (2014) Uptake of silica nanoparticles: neurotoxicity and Alzheimer-like pathology in human SK-N-SH and mouse neuro2a neuroblastoma cells. Toxicol Lett 229(1):240–249Google Scholar
  275. Yemisci M et al (2015) Systemically administered brain-targeted nanoparticles transport peptides across the blood—brain barrier and provide neuroprotection. J Cereb Blood Flow Metab 35(3):469–475Google Scholar
  276. Yin N et al (2013) Silver nanoparticle exposure attenuates the viability of rat cerebellum granule cells through apoptosis coupled to oxidative stress. Small 9(9–10):1831–1841Google Scholar
  277. Yin N et al (2015) Vitamin E attenuates silver nanoparticle-induced effects on body weight and neurotoxicity in rats. Biochem Biophys Res Commun 458(2):405–410Google Scholar
  278. Yiu HH et al (2012) Fe 3 O 4-PEI-RITC magnetic nanoparticles with imaging and gene transfer capability: development of a tool for neural cell transplantation therapies. Pharm Res 29(5):1328–1343Google Scholar
  279. Yoo Y-e et al (2004) Iron enhances NGF-induced neurite outgrowth in PC12 cells. Molecules & Cells (Springer Science & Business Media BV) 17(2):21Google Scholar
  280. You R et al (2018) Silica nanoparticles induce neurodegeneration-like changes in behavior, neuropathology, and affect synapse through MAPK activation. Part Fibre Toxicol 15(1):28Google Scholar
  281. Yu J, Lyubchenko YL (2009) Early stages for Parkinson’s development: α-Synuclein misfolding and aggregation. J Neuroimmune Pharmacol 4(1):10Google Scholar
  282. Yuan Z-Y, Hu Y-L, Gao J-Q (2015) Brain localization and neurotoxicity evaluation of polysorbate 80-modified chitosan nanoparticles in rats. PLoS One 10(8):e0134722Google Scholar
  283. Yuan M, Wang Y, Qin Y-X (2019) Engineered nanomedicine for neuroregeneration: light emitting diode-mediated superparamagnetic iron oxide-gold core-shell nanoparticles functionalized by nerve growth factor. Nanomed Nanotechnol Biol Med 21:102052Google Scholar
  284. Ze Y et al (2013) Molecular mechanism of titanium dioxide nanoparticles-induced oxidative injury in the brain of mice. Chemosphere 92(9):1183–1189Google Scholar
  285. Ze Y et al (2014) Neurotoxic characteristics of spatial recognition damage of the hippocampus in mice following subchronic peroral exposure to TiO2 nanoparticles. J Hazard Mater 264:219–229Google Scholar
  286. Zeng Y et al (2016a) Effects of PAMAM dendrimers with various surface functional groups and multiple generations on cytotoxicity and neuronal differentiation using human neural progenitor cells. J Toxicol Sci 41(3):351–370Google Scholar
  287. Zeng Y et al (2016b) Effects of polyamidoamine dendrimers on a 3-d neurosphere system using human neural progenitor cells. Toxicol Sci 152(1):128–144Google Scholar
  288. Zhang Y et al (2010) Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 cells. ACS Nano 4(6):3181–3186Google Scholar
  289. Zhang L et al (2011) Rutile TiO2 particles exert size and surface coating dependent retention and lesions on the murine brain. Toxicol Lett 207(1):73–81Google Scholar
  290. Zhao Y et al (2015) Translocation and neurotoxicity of CdTe quantum dots in RMEs motor neurons in nematode Caenorhabditis elegans. J Hazard Mater 283:480–489Google Scholar
  291. Zheng X et al (2015) Intranasal H102 peptide-loaded liposomes for brain delivery to treat Alzheimer’s disease. Pharm Res 32(12):3837–3849Google Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  • Amani H. Alhibshi
    • 1
    Email author
  • Widyan A. Alamoudi
    • 1
  • Rai K. Farooq
    • 1
  1. 1.Department of Neuroscience Research, Institute for Research and Medical Consultations (IRMC)Imam Abdulrahman Bin Faisal UniversityDammamSaudi Arabia

Personalised recommendations